Henry Schein has completed a $250 million investment deal with KKR, adding two experienced health care leaders to its board as part of its strategic growth plan.
Henry Schein Inc announced the completion of a $250 million strategic investment by funds affiliated with KKR, giving the investment firm approximately 12% ownership in the company.
New Board Appointments Bring Health Care and Operational Expertise
As part of the transaction, two leaders with deep experience in health care and operations have joined Henry Schein’s Board of Directors. William K. “Dan” Daniel, executive advisor to KKR and former executive vice president of Danaher Corp, has joined the board as an independent director. He is joined by Max Lin, partner at KKR and leader of its health care industry team in the Americas, who was appointed to the board earlier this month.
Lin, who has led multiple investments in dental services, medical products, and health care technology since joining KKR in 2005, was also named vice chair of the Nominating and Governance Committee. Daniel was appointed to the Compensation Committee, and both will serve on the Strategic Advisory Committee.
READ MORE: Henry Schein Dental Merchandise Sales Up, Equipment Flat in Q1 2025 Reporting
Leadership Comments on Strategic Direction
“We are pleased to welcome Max and Dan to the Board as we embark on this exciting next chapter for Henry Schein,” said Stanley M. Bergman, chairman of the board and CEO of Henry Schein. “Their deep experience in health care, operations, and strategic growth will be invaluable as we continue executing on our BOLD+1 strategy and creating long-term value for our stakeholders.”
Photo: ID 229441700 © Andrii Yalanskyi | Dreamstime.com
